CMPS

Compass Pathways Plc ADR

11.57

Oct 30 • 3:59 PM ET -0.62 (-5.09%)

11.60

Aftermarket • 7:59 PM ET +0.03 (0.27%)

Healthcare Medical Care Facilities United Kingdom Small NASD

Peers: DFTX HELP GHRS AXSM DRUG SUPN ACAD NBIX ALKS CMND

| Held by: ARKG IBB PSIL ORR SBIO TMSL GWX SURI HTEC AADR

Scroll to Statements

Index	-
Market Cap	1.60B
Enterprise Value	1.22B
Income	-407.35M
Sales	0.00M
Book/sh	0.62
Cash/sh	3.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	156
IPO	Sep 18, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	18.58
P/C	3.69
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	1.30
Current Ratio	1.30
Debt/Eq	0.65
LT Debt/Eq	0.62
Option/Short	Yes / Yes

EPS (ttm)	-4.62
EPS next Y	-1.66
EPS next Q	-0.36
EPS this Y	26.83%
EPS next Y	26.18%
EPS next 5Y	27.55%
EPS past 3/5Y	-12.71% -12.77%
Sales past 3/5Y	- -
EPS Y/Y TTM	-99.37%
Sales Y/Y TTM	-
EPS Q/Q	-352.05%
Sales Q/Q	-
Earnings	Nov 03 BMO
EPS/Sales Surpr.	-384.41% -

Insider Own	1.61%
Insider Trans	0.00%
Inst Own	66.13%
Inst Trans	-2.51%
ROA	-102.08%
ROE	-329.72%
ROIC	-296.74%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.09%
SMA50	-10.37%
SMA200	11.25%
Trades

Shs Outstand	138.48M
Shs Float	136.24M
Short Float	12.97%
Short Ratio	6.69
Short Interest	17.67M
52W High	15.87 -27.10%
52W Low	4.88 137.09%
Volatility	5.49% 5.23%
ATR (14)	0.65
RSI (14)	45.55
Beta	2.44
Rel Volume	0.83
Avg Volume	2.64M
Volume	2,179,992

Perf Week	3.49%
Perf Month	-3.18%
Perf Quarter	2.84%
Perf Half Y	28.41%
Perf YTD	67.68%
Perf Year	83.65%
Perf 3Y	105.14%
Perf 5Y	-72.58%
Perf 10Y	-
Recom	1.17
Target Price	23.35
Prev Close	12.19
Price	11.57
Change %	-5.09%

Consensus

Strong Buy

Avg. Price Target

$23.35

Implied Upside

+101.8%

Analysts17incl. previous ratings

Rating Distribution16 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jul 27, 2026	Initiated	WWells Fargo	Equal Weight	$13	+12.4%
Jul 08, 2026	Upgrade	EEvercore ISI	In-line → Outperform	$21	+81.5%
May 22, 2026	Initiated	WWolfe Research	Outperform
May 04, 2026	Initiated	JJefferies	Buy	$18	+55.6%
Apr 24, 2026	Initiated	RB. Riley Securities	Buy	$17	+46.9%
Dec 10, 2025	Upgrade	OOppenheimer	Perform → Outperform	$15	+29.6%
Jun 23, 2025	Downgrade	EEvercore ISI	Outperform → In-line	$11 → $6	-48.1%
Feb 27, 2025	Initiated	SStifel	Buy	$11	-4.9%
Jul 23, 2024	Initiated	RRBC Capital Mkts	Outperform	$23	+98.8%
Apr 01, 2024	Initiated	MMorgan Stanley	Overweight	$30	+159.3%
Dec 12, 2023	Initiated	DDeutsche Bank	Buy	$16	+38.3%
Nov 21, 2022	Resumed	BBerenberg	Buy	$33	+185.2%
Nov 01, 2022	Initiated	LLoop Capital	Buy	$34	+193.9%
Oct 29, 2021	Initiated	OOppenheimer	Outperform	$50	+332.2%
Jul 13, 2021	Initiated	CCitigroup	Buy	$67	+479.1%
Jun 28, 2021	Initiated	MMaxim Group	Buy	$70	+505.0%
May 11, 2021	Initiated	CCantor Fitzgerald	Overweight	$71	+513.7%
Apr 01, 2021	Initiated	RROTH Capital	Buy	$88	+660.6%
Oct 14, 2020	Initiated	HH.C. Wainwright	Buy	$65	+461.8%
Oct 13, 2020	Initiated	EEvercore ISI	Outperform

Oct-28-26 06:30AM	Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress (Business Wire)
Oct-27-26 12:49PM	Compass Pathways Earnings Hinge On FDA Review Progress And DEA Rescheduling Path For Comp360 (Earnings Whispers) +6.88%
06:30AM	Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026 (Business Wire)
Oct-14-26 06:30AM	Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day (Business Wire)
Oct-02-26 06:30AM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
06:30AM	Loading…
Sep-30-26 06:30AM	Compass Pathways Appoints Kelley Boucher as Chief People Officer (Business Wire)
Sep-16-26 06:30AM	Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 (Business Wire)
Sep-15-26 06:30AM	Compass Pathways Launches 'Change the Tune in TRD' in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026 (Business Wire) -5.02%
Sep-10-26 08:00AM	Fluence Selected by Compass Pathways to Develop Post-Approval COMP360 Provider Training (PR Newswire) -6.26%
06:35AM	Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training (Business Wire)
06:30AM	Compass Pathways to Participate in Investor Conferences the Week of September 14th (Business Wire)
Sep-09-26 12:19PM	Compass Pathways stock rises as 52-week data show lasting depression relief (Proactive) +8.05%
10:06AM	CMPS Stock Defies Market Selloff After Compass Pathways Psilocybin Trial Success Pointing To 2027 Launch (Stocktwits)
08:48AM	Compass Pathways reports 52-week Phase 3 COMP005 results for COMP360 (InvestorsHub)
07:56AM	Wall Street slips for a third straight day as oil and yields climb (Proactive)
07:56AM	Loading…
07:56AM	Dow leads markets lower as oil shock hits stocks (Proactive)
06:30AM	Compass Pathways' New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year (Business Wire)
Sep-08-26 06:28PM	CMPS Stock Rallies On Launch-Prep Push Ahead Of FDA Psychedelics Hearing (Stocktwits) +5.80%
06:30AM	Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026 (Business Wire)
Sep-03-26 04:30PM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-02-26 06:30AM	Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree (Business Wire)
Sep-01-26 06:30AM	Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026 (Business Wire)
Aug-24-26 07:23PM	CMPS Stock Clocks 25% Gains In August Ahead Of Application Filing For Drug, FDA Hearing On Psychedelics (Stocktwits) +6.53%
Aug-10-26 08:54AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Aug-06-26 07:00AM	Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026 (Business Wire)
Aug-05-26 04:30PM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +15.08%
03:01PM	Compass Pathways PLC (CMPS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and NDA ... (GuruFocus.com)
06:30AM	Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights (Business Wire)
Jul-29-26 06:30AM	Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026 (Business Wire)
Jul-27-26 10:38AM	CMPS, MDGL, DFTX, GHRS, HELP Stocks In Spotlight Today Why Wells Fargo Thinks Next Wave Of Depression Drugs Could Create New Winners (Stocktwits)
01:25PM	Loading…
Jul-22-26 01:25PM	Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva (IPO-Edge.com)
Jul-21-26 09:00AM	A Depression Drug Just Cleared a Key Hurdle Early, and the Market for New Mental Health Treatments Keeps Widening (PR Newswire)
08:30AM	Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates (PR Newswire)
Jul-17-26 12:50PM	Compass Pathways gains Jefferies support as COMP360 data distinguishes psychological support from psychotherapy (Proactive)
08:50AM	Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time (PR Newswire)
Jul-16-26 07:44AM	Why Psychedelic stocks are surging today (Investing.com) -6.61%
07:42AM	ATAI Stock Soars On Eli Lillys $2.8B Buyout Why Are CMPS Shares Rising Too? (Stocktwits)
06:35AM	Compass Pathways Announces Publication of Post-Hoc Analysis Demonstrating Distinction of COMP360 Trial Monitoring & Support from Psychotherapy (Business Wire)
Jul-15-26 03:34PM	Johnson & Johnsons Spravato sales growth supports psychedelic drug opportunity: Jefferies (Proactive)
Jul-14-26 03:00PM	The Race to Commercialize the Worlds Most Powerful Psychedelic (WSJ)
Jul-13-26 04:01PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
02:59PM	Psychedelics guidance from the FDA set to benefit developers, including AtaiBeckley, Jefferies says (Proactive)
Jul-10-26 08:57AM	Cathie Wood Dumps AMD, Doubles Down on Meta Stock (GuruFocus.com)
Jul-08-26 09:28PM	CMPS Stock Climbs After-Hours: Analyst Sees Depression Drug Approval By H1 2027 Or Sooner After Strong Trial Data (Stocktwits) +7.51%
Jul-07-26 06:13PM	CMPS Stock Clocks Muted Gains But Analysts Back Psychedelic Drugs Durability Ahead Of FDA Filing (Stocktwits)
09:49AM	Why Psychedelics-Tied Compass Pathways Isn't Getting High (Investor's Business Daily)
08:15AM	Compass Pathways Clears Another Hurdle Builds Stronger FDA Case For Its Much-Awaited Depression Therapy (Stocktwits)
06:30AM	Compass Pathways Announces Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile (Business Wire)
Jul-02-26 06:30AM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-26-26 09:30AM	A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year (PR Newswire) +9.13%
Jun-24-26 07:00AM	3 Companies Redefining Healthcare Innovation (ETF Trends)
06:56AM	To Wall Street, psychedelics biotechs are more teammates than rivals (BioPharma Dive)
Jun-05-26 06:30AM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.20%
May-28-26 06:30AM	Compass Pathways Elects Kathleen Tregoning to Board of Directors (Business Wire)
May-26-26 06:30AM	Compass Pathways to Participate in Jefferies Global Healthcare Conference on June 3, 2026 (Business Wire)
May-18-26 10:08AM	This Psychedelics Stock Just Keeps Getting Hotter; Why Shares Bypassed A Profit-Taking Zone (Investor's Business Daily)
May-14-26 06:30AM	Compass Pathways to Participate in RBC Capital Markets Global Healthcare Conference on May 19-20, 2026 (Business Wire)
May-13-26 07:02PM	Compass Pathways PLC (CMPS) Q1 2026 Earnings Call Highlights: Promising Advances in ... (GuruFocus.com) +16.97%
12:39PM	Here's Why This Psychedelics Stock Just Took A Trip To A Two-Year High (Investor's Business Daily)
12:33PM	Compass Pathways shares rise on Q1 results, accelerated FDA review (Proactive)
08:54AM	Compass Pathways jumps after earnings beat and accelerated FDA review progress (CMPS) (InvestorsHub)
07:48AM	Nasdaq continues to gain but Dow still red as Trump arrives in China (Proactive)
06:30AM	Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights (Business Wire)
May-06-26 06:30AM	Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 2026 (Business Wire)
06:25AM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-27-26 09:16AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive) -7.20%
Apr-24-26 03:59PM	FDA Fast-Tracks Review of Some Psychedelic Drugs. This Stock Is Set to Benefit. (Barrons.com)
11:58AM	Psychedelic Pharma Stocks Are Riding High. Past Cannabis Returns Are a Reality Check. (Barrons.com)
10:37AM	Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher (Business Wire)
Apr-22-26 08:49AM	Can I have some, please?: Trump jokes as he signs psychedelics order after Joe Rogan push. These stocks soar (Moneywise) -5.41%
Apr-21-26 06:30AM	Compass Pathways Collaborates with Osmind to Advance Independent Clinic Readiness for Psychedelic Treatments (Business Wire)
Apr-20-26 02:34PM	Market Feels Weak, But Stocks Tell Stories (GuruFocus.com) +42.04%
12:41PM	Trump Signs Psychedelic Drugs Order. 4 Stocks That Are Surging. (Barrons.com)
11:48AM	Trump Pushes for Speedy Psychedelic Approvals, Sending Stocks Surging (The Wall Street Journal)
10:01AM	How Trump Sent Psychedelics-Tied Compass Pathways And Others Flying (Investor's Business Daily)
08:26AM	Psychedelic stocks rally with Trump's support (MarketWatch)
08:18AM	Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring. (Barrons.com)
06:30AM	Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 2026 (Business Wire)
05:53AM	Psychedelic stocks soar after Trump signs executive order to fast-track treatments (Investing.com)
Apr-18-26 04:12PM	Compass Pathways Commends White House Executive Order to Accelerate Research and Access for Psychedelic Treatments (Business Wire)
Apr-17-26 04:00AM	Can an LSD candidate do for anxiety what Spravato did for depression? (Pharma Voice)
Apr-14-26 06:30AM	Compass Pathways Announces U.S Grant Program for the Creation of Post-Approval COMP360 Provider Training (Business Wire)
Apr-08-26 06:30AM	Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026 (Business Wire)
Apr-07-26 04:30PM	Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-29-26 10:25AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Mar-24-26 07:30AM	Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights (Business Wire)
Mar-12-26 06:30AM	Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 (Business Wire)
Mar-10-26 07:30AM	Cathie Wood Bets $19 Million on 5 Beaten-Down Stocks (Barchart) +8.45%
Mar-09-26 10:50AM	CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions (PR Newswire)
Mar-08-26 02:03PM	Compass Pathways Highlights Phase 3 COMP360 TRD Gains, 26-Week Durability and FDA Path at Conference (MarketBeat)
Feb-26-26 12:07PM	Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders (PR Newswire)
06:30AM	Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants (Business Wire)
Feb-24-26 09:35AM	Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity (PR Newswire)
06:39AM	Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026 (Business Wire)
Feb-23-26 03:00AM	How does the FDA really feel about psychedelics? We could soon find out. (Pharma Voice)
Feb-22-26 07:43PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Feb-20-26 11:14AM	Magic Mushrooms, Hard Cash: Compass Pathways' Trial Win, Fast Raise (MarketBeat)
10:01AM	Cathie Wood Pours $24 Million to This AI Software Stock (GuruFocus.com)
09:40AM	Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? (Zacks)
Feb-19-26 11:40AM	The FDA could approve key component of magic mushrooms as a depression treatment (Quartz)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jenkins Annalisa	Former Director	Aug 10 '26	Proposed Sale	13.30	26,000	345,799		Aug 10 01:26 PM
Jenkins Annalisa	Former Director	Aug 07 '26	Proposed Sale	13.72	83,771	1,149,153		Aug 07 11:35 AM

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

M.B.A.Mr. Kabir Kumar Nath M.A.

Chief Financial OfficerMs. Teri Loxam M.B.A.

Chief Medical OfficerDr. Guy Goodwin

Senior Vice President of Investor RelationsMr. Stephen D. Schultz

Chief People OfficerMs. Kelley Boucher

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CMPS

Compass Pathways Plc ADR

Upgrade your Finviz experience